Eli Lilly has filed lawsuits against MangoRx and two other companies for allegedly selling unauthorized tirzepatide products, raising serious patient safety concerns.
MangoRx has introduced TRIM, an oral dissolvable Tirzepatide tablet, priced at $399 per month, offering a convenient alternative to injectable weight loss therapies.